1. Academic Validation
  2. Mycobacterium tuberculosis growth inhibition by constituents of Sapium haematospermum

Mycobacterium tuberculosis growth inhibition by constituents of Sapium haematospermum

  • J Nat Prod. 2004 Apr;67(4):598-603. doi: 10.1021/np0303411.
Girma M Woldemichael 1 Maria-Teresa Gutierrez-Lugo Scott G Franzblau Yuehong Wang Enrique Suarez Barbara N Timmermann
Affiliations

Affiliation

  • 1 Department of Pharmacology and Toxicology, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Arizona, 1703 E. Mabel Street, Tucson, Arizona 85721-0207, USA.
Abstract

Four novel compounds consisting of two new pimaranes, lecheronol A (1) and lecheronol B (2), an acylated cycloartane, 3-O-beta-lauroyl-cycloart-(23E)-en-25-ol (10), and a highly oxygenated novel chalconoid, alpha,beta,3,4,5,2',4',6'-octahydroxydihydrochalcone (12), were isolated along with seven known triterpene derivatives and three flavonol glucosides from Mycobacterium tuberculosis growth-inhibiting fractions of the CH(2)Cl(2)/MeOH (1:1) extract of the aerial parts of Sapium haematospermum. Compounds 1, 3 (3 alpha-hydroxyolean-12-ene), 8 [3 alpha-hydroxylup-20(29)-en], and 9 (cycloartanol) were found most active, with MIC values of 4, 12.2, 13.4, and 8 microg/mL, respectively. Cytotoxicity tests in Vero cells for compounds 1, 3, 8, and 9 gave IC(50) values of 104.8, 127.2, 127.2, and 102.4 microg/mL, respectively.

Figures